Lunch break & Poster Viewing
| Friday, December 6, 2024 |
| 12:20 - 13:50 |
| Level -2 |
Speaker
Dr. Jure Aljinović
Clinical Hospital Split, University Of Split
HLA DRB1*04 Allele is Uncommon in the Spondyloarthritis and Psoriatic Arthritis Group Compared to the HLA B*44 Group Average and the Rheumatoid Arthritis Group
Mr. Matija Bajželj
University Medical Centre Ljubljana, Department of Rheumatology
Haptoglobin Genotyping in Adult IgAV Patients
Dr. Jiří Baloun
Institute Of Rheumatology
Clinical Indicators of Difficult-to-Treat Rheumatoid Arthritis Revealed by Machine Learning
Sandra Beer
University Medical Centre Ljubljana
Nutritional counselling in patients with rheumatologic diseases
Ms. Masa Bizjak
UKC Ljubljana
Safety, Effectiveness and Immunogenicity of Varicella Vaccination in Children With Juvenile Idiopathic Arthritis Treated With Anticytokine Therapy
Dr. Klara Dai
University Clinical Centre Maribor
Relapsing Polychondritis Associated With Bilateral Scleritis and Heart Block – Case Report and Literature Review
Dr. Radosław Dziedzic
Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences
The Usefulness of the CHA2DS2-VASc Score to Predict Ischemic Stroke in Systemic Lupus Erythematosus Patients Without Atrial Fibrillation – A Single-Centre Retrospective Study
Dr. Diána Garan
Semmelweis University
Psychological Skills of Patients With Juvenile Idiopathic Arthritis: A Cross-Sectional Study at a Hungarian Paediatric Rheumatology Center
Prof. Bogna Grygiel–Górniak
Department Of Rheumatology, Rehabilitation And Internal Medicine
Susac Syndrome – Different Treatment Approaches for One Disease (Analysis of Case Series)
Dr. Zofia Guła
University Hospital, Division Of Rheumatology, Immunology And Internal Medicine, Kraków, Poland
Depression and Anxiety Are Substantially Underrecognized in Ra, axSpA and PSA – Data From Real-World Rheumatological Practice
Dr. Nestani Gvetadze
Tbilisi State Medical University
The Role of Complete Blood Count Derived Biomarkers in Rheumatoid Arthritis Patients Undergoing Treatment with Tocilizumab
Dr. Alojzija Hocevar
UMC Ljubljana
The Incidence of Whipple’s Disease in Ljubljana and Gorenjska Region
Dr. Alojzija Hocevar
UMC Ljubljana
Our Experiences With IgG4 Related Disease
Dr. Stela Hrkač
Dubrava University Hospital
RACAND Syndrome in a 80-Year-Old Woman – a Case Report
Ms. Eva Husain
Faculty Of Pharmacy, University Of Ljubljana
Comparative Analysis of Anti-Double Stranded DNA Antibodies Detection Assays
Dr. Tobiasz Kardas
Chair and Department of Rheumatology and Connective Tissue Diseases in Lublin
Comparison of the Use of Clinical and Laboratory Indicators of Disease Activity in Systemic Lupus Erythematosus and Primary Sjögren’s Syndrome With Polyarthritis
Mrs. Nastasia Kifer
University Hospital Centre Zagreb
Early Insights From the Juvenile Inflammatory Rheumatism (Jir)-Clips Igav Network –Strategies for Managing Atypical Skin Manifestations in Igav
Ms. Brigita Koren
University Medical Centre Maribor
Prevalence of Familial Autoimmune Diseases in Juvenile Idiopathic Arthritis
Dr. Joanna Kosałka-Węgiel
Jagiellonian Univerity Medical College
Monoclonal Gammopathy in Systemic Lupus Erythematosus: Clinical Course, Malignancy Risk, and Mortality Rate – a Single-Center Retrospective Cohort Study
Dr. Kristina Kovač Durmiš
University of Zagreb School of Medicine
Assessment of Cognitive Functions in Psoriatic Arthritis Patients
Dr. Piotr Kuszmiersz
Jagiellonian University
Implementation of GoTreatIT® Software Enhances Treat-To-Target Strategy in Axial Spondylarthritis Patients Care: Results From POLNOR-Rheuma Cohort Study
Dr. Lilla Lengvári
Semmelweis University
Streamlined Genetic Diagnosis and Management of Autoinflammatory Diseases: A Collaborative Initiative in Hungary
Dr. Maria Maślińska
National Institute of Geriatrics, Rheumatology and Rehabilitation
The Clinical Phenotypes of Patients With IgG4 – Related Disease Depending on Sex – Observations From One Clinical Centre
Prof. Jasminka Milas-Ahić
Clinical Hospital Center Osijek
Pulmonary Manifestations in Patients With Rheumatoid Arthritis
Dr. Filip Miric
Clinical Hospital Center Rijeka
Combination of Rituximab and Tofacitinib in Treatment of Anti-MDA5 Antibody Positive Dermatomyositis – Two Case Reports
Dr. Adela Navratilova
Institute of Rheumatology
Il-40 Is Up-Regulated in the Synovial Fluid and Cartilage of Osteoarthritis Patients and Contributes to the Alteration of Chondrocytes Phenotype In Vitro
Dr. Manca Ogrič
University Medical Centre Ljubljana, Department of Rheumatology
Can We Predict the Need for Treatment With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs at the Time of Diagnosis of Rheumatoid Arthritis?
Dr. Sabína Oreská
Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech R
Assessment of Cardiovascular Risk in Patients With Systemic Sclerosis – Testing the Tools Based on Score and Its Modifications Compared to Ultrasound Examination of Subclinical Atherosclerosis
Dr. Sabína Oreská
Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech R
Rituximab in csDMARD-Refractory Systemic Sclerosis – Preliminary Data From a Prospective, Observational, Monocenter Study
Prof. Dijana Perkovic
University Hospital of Split
Efficiency and Safety Profile of Biologic Agents in Patients With Systemic Lupus Erythematosus: Retrospective Analysis From Single Tertiary Centre
Mrs. Vlasta Petric
Sb Murska Sobota
Peripheral Nerve and Gastrointestinal Involvement in Anca-Negative Eosinophilic Granulomatosis With Polyangiitis – a Case Report
Dr. Bence Pokoly
National Institute of Musculoskeletal Diseases
Scleredema Diabeticorum
Ms. Klára Prajzlerová
Institute of Rheumatology
Pro-inflammatory Monocytes and CD11c Expression in Acpa Positive Individuals With Arthralgia and Their Associations With Subclinical Synovitis Preceding the Onset of Arthritis
Ms. Klára Prajzlerová
Institute of Rheumatology
Cellular miRNA-31 and miRNA-125b as Predictors of Remission in Patients With Early Rheumatoid Arthritis
Mrs. Aneta Prokopcova
Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague
CRTAC1: A Novel Indicator of Lung Involvement in Systemic Sclerosis
Prof. Mislav Radić
Internal Medicine Department, Rheumatology, Allergology, and Clinical Immunology Division, University Hospital of Split
Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients With Triple Positive Antiphospholipid Syndrome – A Systematic Review and Meta-Analysis
Mrs. Marija Rogoznica
Thalassotherapia Opatija
Methotrexate Induced Paradoxical Psoriasis
Dr. Mario Sestan
University Of Zagreb School Of Medicine
A Case Report: Interferonopathy or Nf-Kb Disorder?
Dr. Mario Sestan
University Of Zagreb School Of Medicine
Extended Monitoring of Iga Vasculitis Nephritis Patients: The Croatian National Center’s Findings
Ms. Tjaša Šinkovec Savšek
Department Of Allergology, Rheumatology And Clinical Immunology, Uch, University Medical Centre Ljubljana, Slovenia
The Effect of Cytokine Blocking Agents on the Long-term Immunogenicity of Tetanus Toxoid Vaccine in Children with Rheumatic Diseases
Mrs. Anja Srpčič
Department of Rheumatology, University Medical Centre Ljubljana
Serum Levels of Anti-IL-6 Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
Mrs. Katja Stopar
Splošna Bolnišnica Dr. Franca Derganca Nova Gorica
Serious Multi-Systemic Immune-Related Adverse Events in a Patient With Pleural Mesothelioma Treated With Checkpoint Inhibitors (Ipilimumab – Nivolumab)
Mrs. Szilvia Katalin Szamosi
University of Debrecen
Effectivity and Tolerability of Antifibrotic Therapy in Connective Tissue Disease Associated Interstitial Lung Diseases – Real World Data
Prof. Zoltán Szekanecz
University of Debrecen, Department Of Rheumatology
The Importance of Pain REDuction and Improving Functional Outcomes in Rheumatic Disease Treatment – Etoricoxib in Real-world Clinical Setting: Its Treatment Outcome in Patients with Rheumatic Diseases
Ms. Kata Takács
Semmelweis University
Mevalonate Kinase Deficiency: An Updated Clinical Overview Considering the Revised SHARE Recommendations
Prof. Bożena Targońska-stępniak
Medical University Of Lublin, Poland
The Relationship Between Central Obesity and Disease Activity in Patients with Rheumatoid Arthritis
Prof. Michal Tomcik
Institute of Rheumatology
Increased Systemic S100A4 Levels in Scleroderma-Related Interstitial Lung Disease Decrease with Cyclophosphamide/Rituximab Treatment and Serve as Predictors for Treatment Response and Early Disease Progression
Dr. Krzysztof Wójcik
Jagiellonian University Medical College
Identification of Risk Factors for Exacerbation of Anca-Associated Vasculitis to Build Model of Personalized Maintenance Treatment Regimen
Dr. Maciej Trzaska
Swedish Orphan Biovitrum Sp. Z O.o. Oddział W Polsce
Interim Findings on Patient-Reported Outcomes, Disease Activity and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib for Up To 18 Months from FILOSOPHY and PARROTFISH
Dr. Maciej Trzaska
Swedish Orphan Biovitrum Sp. Z O.o. Oddział W Polsce
Long-Term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study
Dr. Maciej Trzaska
Swedish Orphan Biovitrum Sp. Z O.o. Oddział W Polsce
Updated Safety Analysis of Filgotinib in Moderate to Severe Active Rheumatoid Arthritis Patients Over a Median of 4.3 Years
